| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0099 | 0.9 |